Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129728) titled 'A multicenter real-world study of metabolic regulation combined with progesterone for the care and treatment of obese patients with endometrial cancer and atypical endometrial hyperplasia' on Aug. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Condition:
Endometrial cancer and atypical endometrial hyperplasia in obese patients
Intervention:
The group observing the effect of semaglutide combined with progestin:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-15
Ta...